reports
JD HEALTH INTERNATIONAL sees a downgrade to Negative on account of les...
The independent financial analyst theScreener just lowered the general evaluation of JD HEALTH INTERNATIONAL (HK), active in the Drug Retailers industry. As regards its fundamental valuation, the title now shows 0 out of 4 stars while market behaviour can be considered risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Negative. As of the analysis date February 22, 2022, the closing price was HKD 59.70 and its t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.